apollo
logo
0
  1. Home
  2. Medicine
  3. Glycomet 1 GM Tablet 15's
  4. Health Queries for Glycomet 1 GM Tablet 15's
  5. For an individual with an HbA1c level of 8.5%, what are the clinical considerations and differences in efficacy between initiating Metformin sustained-release 500 mg twice daily versus a Sitagliptin/Metformin combination therapy?

health query

Have a query?

For an individual with an HbA1c level of 8.5%, what are the clinical considerations and differences in efficacy between initiating Metformin sustained-release 500 mg twice daily versus a Sitagliptin/Metformin combination therapy?

Asked by Male, 45 · 10 days ago

With an HbA1c of 8.5%, your blood sugar is a bit high, but we can absolutely get it to a safer range. Metformin sustained-release is a gentle, effective starting medication. However, because your HbA1c is 8.5%, starting with a combination of sitagliptin and metformin may help lower your levels more quickly and effectively. Sitagliptin helps your body release more insulin when needed, while metformin reduces sugar production in your liver. Together, they offer stronger results than metformin alone with very little risk of low blood sugar.
user icon

Ask Apollo

AI powered Health Chatbot

For an individual with an HbA1c level of 8.5%, what are the clinical considerations and differences in efficacy between initiating Metformin sustained-release 500 mg twice daily versus a Sitagliptin/Metformin combination therapy?

Answered 10 days ago

Related Questions